Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Clinical trial NCT00967343 · TERMINATED

Trial details

NCT number: NCT00967343
Sponsor: Kiadis Pharma
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myeloid Leukemia Lymphoblastic Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndrome Myeloproliferative Disorders

Start date: 2009-08-01
Primary completion: 2012-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.